• 2009 September 28

Company Description

Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression

Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series. Sprint Bioscience is based in Stockholm, Sweden.